JFG
NVO

JDM Financial Group’s Novo Nordisk NVO Stock Holding History

JDM Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-95
Closed -$5.27K – 284
2025
Q3 		$5.27K Hold
95
– – ﹤0.01% 231
2025
Q2 		$6.56K Hold
95
– – ﹤0.01% 205
2025
Q1 		$6.6K Hold
95
– – ﹤0.01% 200
2024
Q4 		$8.17K Hold
95
– – ﹤0.01% 192
2024
Q3 		$11.3K Hold
95
– – 0.01% 168
2024
Q2 		$13.6K Hold
95
– – 0.01% 131
2024
Q1 		$17.7K Hold
95
– – 0.01% 111
2023
Q4 		$17.7K Hold
95
– – 0.01% 105
2023
Q3 		$17.7K Sell
95
-95
-50% -$8.37K 0.02% 98
2023
Q2 		$15.4K Hold
190
– – 0.01% 112
2023
Q1 		$15.1K Hold
190
– – 0.01% 115
2022
Q4 		$12.9K Buy
+190
New +$11.1K 0.01% 120

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JDM Financial Group's NVO Position: Q4 2025 in Review

JDM Financial Group sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 95 shares — an estimated $5.27K sold.

JDM Financial Group first reported a position in NVO in Q4 2022 and held it in 12 quarters. The position peaked at $17.7K in Q1 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • JDM Financial Group reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • JDM Financial Group sold 95 Novo Nordisk shares in Q4 2025, an estimated $5.27K.
  • JDM Financial Group first reported a position in Novo Nordisk in Q4 2022 and held it in 12 quarters.
  • JDM Financial Group's Novo Nordisk position peaked at $17.7K in Q1 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on JDM Financial Group's 13F filing for Q4 2025, filed 2 Feb 2026.